Ljubljana/biobricks
From 2007.igem.org
(Difference between revisions)
m |
|||
| Line 40: | Line 40: | ||
<div></div></form> | <div></div></form> | ||
| - | + | <small> | |
<TABLE class='pgrouptable addborder' style='width: 600px;' cellpadding='0' cellspacing='0' border="0" style="background:#d0d2fb"><TR><TH colspan='2' style='width: 1em' nowrap><A style='color:blue;text-decoration:none;' | <TABLE class='pgrouptable addborder' style='width: 600px;' cellpadding='0' cellspacing='0' border="0" style="background:#d0d2fb"><TR><TH colspan='2' style='width: 1em' nowrap><A style='color:blue;text-decoration:none;' | ||
href='http://partsregistry.org/Help:Availability_and _usefulness'></A><TH style='width: 7em;'>Name</TH><TH>Type<TH>Description<TH>Length<TH class='blank_col'> | href='http://partsregistry.org/Help:Availability_and _usefulness'></A><TH style='width: 7em;'>Name</TH><TH>Type<TH>Description<TH>Length<TH class='blank_col'> | ||
| Line 257: | Line 257: | ||
<!-- end content --> | <!-- end content --> | ||
| - | + | </small> | |
Revision as of 22:18, 26 October 2007
Biobricks
This year, our team has been the driving force of expanding the registry, creating no less than 77 parts. For our purpose we created, in addition to other parts, biobricks coding for individual domains of multi-domain proteins, involved in cellular signalling and antiviral response. These provide particular enrichment of the registry as they allow endless possibility to readily create novel chimeric proteins.
